Sex differences during drug development
Trinkle, R.
Canadian Journal of Clinical Pharmacology 6(3): 136
1999
ISSN/ISBN: 1198-581X PMID: 10610273 Document Number: 506844
Document emailed within 1 workday
Related Documents
Skipper, H.E. 1990: Tumor differences, drug differences, treatment design differences, and effects on therapeutic outcome (degree and duration of therapeutic response) Progress in Clinical and Biological Research 354a: 81-98Whitehouse, P.J.; Sciulli, C.G.; Mason, R.M. 1997: Dementia drug development: use of information systems to harmonize global drug development Psychopharmacology Bulletin 33(1): 129-133
Ciorciaro, C.; Hartmann, K.; Kuhn, M. 1998: Differences in the relative incidence of adverse drug reactions in relation to age? An evaluation of the spontaneous reporting system of SANZ (Swiss Drug Monitoring Center) Schweizerische Medizinische Wochenschrift 128(7): 254-258
Kelloff, G.J.; Crowell, J.A.; Boone, C.W.; Steele, V.E.; Lubet, R.A.; Greenwald, P.; Alberts, D.S.; Covey, J.M.; Doody, L.A.; Knapp, G.G. 1994: Strategy and planning for chemopreventive drug development: clinical development plans. Chemoprevention Branch and Agent Development Committee. National Cancer Institute Journal of Cellular Biochemistry. Supplement 20: 55-62
Kutter, E.; Austel, V. 1981: Application of the theory of sets to drug design. Development of a new cardiotonic drug AR-L 115 BS Arzneimittel-Forschung 31(1a): 135-141
Alhenc-Gelas, Fçois.; Parmentier, L.; Bisagni, A. 2003: Pharmacogenetic and pharmacogenomic studies. Impact on drug discovery and drug development Therapie 58(3): 275-282
Thomas, J.W. 1995: AHi perspectives: flexible drug labeling and its impact on the drug development process. Liability issues Journal of the American Veterinary Medical Association 207(7): 899-900; Discussion: 902-904
Vetticaden, S.J. 1988: Polymorphic differences in drug metabolism and response Methods and Findings in Experimental and Clinical Pharmacology 10(8): 531-536
Sjöqvist, F.; von Bahr, C. 1973: Interindividual differences in drug oxidation: clinical importance Drug Metabolism and Disposition: the Biological Fate of Chemicals 1(1): 469-482
McCoy, H.V.; Correa, R.; Fritz, E. 1996: HIV diffusion patterns and mobility: Gender differences among drug users Population Research and Policy Review 15(3): 249-264
Nebert, D.W. 1981: Birth defects and the potential role of genetic differences in drug metabolism Birth Defects Original Article Series 17(1): 51-70
Røttingen, J.A.; Frich, J.C. 2001: Development of infectious diseases--a consequence of differences? Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 121(7): 841-844
Mitro, A.; Schiebler, T.H. 1972: Development of regional differences in 3d ventricle ependyma of the rat Anatomischer Anzeiger 132(1): 1-9
Erikson, J.H.; Frykholm, B. 1977: Differences between opiate, multi-drug and amphetamine abusers in voluntary treatment programs Lakartidningen 74(48): 4323-4325
Andronova, L.M.; Barkov, N.K. 1981: Role of sex differences and changes in sexual functioning in drug addiction and its treatment (review of the literature) Farmakologiia i Toksikologiia 44(3): 362-376
Kretzschmar, M.; Zhang, W.; Mikolajczyk, R.T.; Wang, L.; Sun, X.; Kraemer, A.; Lv, F. 2008: Regional differences in HIV prevalence among drug users in China: potential for future spread of HIV? Bmc Infectious Diseases 8: 108
Eaton, Y.M.; Mitchell, M.L.; Jolley, J.M. 1991: Gender differences in the development of relationships during late adolescence Adolescence 26(103): 565-568
Hedden, S.L.; Whitaker, D.; Floyd, L.; Latimer, W.W. 2009: Gender differences in the prevalence and behavioral risk factors of HIV in South African drug users Aids and Behavior 13(2): 288-296
Loikas, D.ée.; Wettermark, B.ör.; Von Euler, M.; Bergman, U.; Weitoft, G.R.äc.; Schenck-Gustafsson, K. 2011: Big gender differences in drug utilization. the underlying disease is an insufficient explanation according to a systematic analysis Lakartidningen 108(40): 1957-1962
Terzian, L.A.; Stahler, N.; Dawkins, A.T. 1970: Differences in drug response of the sporogonous cycles of three strains of Plasmodium falciparum in Anopheles stephensi Research Communications in Chemical Pathology and Pharmacology 1(1): 16-24